These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10435064)

  • 1. Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathy.
    Gerding MN; van der Zant FM; van Royen EA; Koornneef L; Krenning EP; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):373-9. PubMed ID: 10435064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (99m)Tc-HYNIC-TOC scintigraphy in evaluation of active Graves' ophthalmopathy (GO).
    Sun H; Jiang XF; Wang S; Chen HY; Sun J; Li PY; Ning G; Zhao YJ
    Endocrine; 2007 Jun; 31(3):305-10. PubMed ID: 17906380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy: a disease activity parameter that predicts the therapeutic response to immunosuppressive treatment.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2005 Apr; 15(4):358-63. PubMed ID: 15876160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy.
    Kahaly G; Diaz M; Hahn K; Beyer J; Bockisch A
    J Nucl Med; 1995 Apr; 36(4):550-4. PubMed ID: 7699440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy.
    Kahaly G; Diaz M; Just M; Beyer J; Lieb W
    Thyroid; 1995 Apr; 5(2):107-11. PubMed ID: 7647569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin-receptor scintigraphy in Graves' disease: reproducibility and variance of orbital activity.
    Förster GJ; Krummenauer F; Nickel O; Kahaly GJ
    Cancer Biother Radiopharm; 2000 Oct; 15(5):517-25. PubMed ID: 11155823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotide.
    Moncayo R; Baldissera I; Decristoforo C; Kendler D; Donnemiller E
    Thyroid; 1997 Feb; 7(1):21-9. PubMed ID: 9086565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters.
    Gerding MN; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2000 May; 52(5):641-6. PubMed ID: 10792345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Octreotide scintigraphy for the diagnosis of active Graves' ophthalmopathy].
    Ardjomand N; Esche G; Fellner P; Lindner S; Panzitt M; Aigner R; Langmann A
    Ophthalmologe; 2003 Dec; 100(12):1049-53. PubMed ID: 14704818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy.
    Savastano S; Pivonello R; Acampa W; Salvatore M; Lombardi G; Colao A; Fenzi G
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2440-4. PubMed ID: 15687327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical application of orbital scintigraphy with 99Tc(m)-octreotide in patients with thyroid associated ophthalmopathy].
    Duan L; Li XF; Lu KY; Zhang CG; Hu G; Liu JZ; Li SJ
    Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1068-72. PubMed ID: 17415962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 111In-octreotide imaging in patients with long-standing Graves' ophthalmopathy.
    Bohuslavizki KH; Oberwöhrmann S; Brenner W; Eberhardt JU; Mönig H; Clausen M; Sippel C; Wolf H; Epe B; Henze E
    Nucl Med Commun; 1995 Nov; 16(11):912-6. PubMed ID: 8587756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
    Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmos.
    Mansi L; Rambaldi PF; Bizzarro A; Panza N; Di Martino S; De Bellis A; Del Vecchio E
    Q J Nucl Med; 1995 Jun; 39(2):105-10. PubMed ID: 8574802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?
    Postema PT; Krenning EP; Wijngaarde R; Kooy PP; Oei HY; van den Bosch WA; Reubi JC; Wiersinga WM; Hooijkaas H; van der Loos T
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1845-51. PubMed ID: 7989493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.
    Burggasser G; Hurtl I; Hauff W; Lukas J; Greifeneder M; Heydari B; Thaler A; Wedrich A; Virgolini I
    J Nucl Med; 2003 Oct; 44(10):1547-55. PubMed ID: 14530465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indium-111-pentetreotide in Graves' disease.
    Kahaly G; Görges R; Diaz M; Hommel G; Bockisch A
    J Nucl Med; 1998 Mar; 39(3):533-6. PubMed ID: 9529305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy.
    Ujhelyi B; Erdei A; Galuska L; Varga J; Szabados L; Balazs E; Bodor M; Cseke B; Karanyi Z; Leovey A; Mezosi E; Burman KD; Berta A; Nagy EV
    Thyroid; 2009 Apr; 19(4):375-80. PubMed ID: 19355827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.